Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DIDANOSINE for Hiv infection who clinical stage iii: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 9 adverse event reports in the FDA FAERS database where DIDANOSINE was used for Hiv infection who clinical stage iii.

Most Reported Side Effects for DIDANOSINE

Side Effect Reports % Deaths Hosp.
Foetal exposure during pregnancy 472 22.9% 75 116
Lipodystrophy acquired 216 10.5% 1 5
Eyelid ptosis 191 9.3% 0 4
Drug resistance 189 9.2% 10 13
Virologic failure 187 9.1% 9 14
Mitochondrial toxicity 174 8.4% 2 3
Viral mutation identified 171 8.3% 1 0
Diplopia 170 8.2% 0 0
Treatment failure 170 8.2% 17 2
Pathogen resistance 135 6.5% 3 6
Pregnancy 123 6.0% 6 32
Blood lactic acid increased 104 5.0% 1 45
Dysphagia 97 4.7% 0 4
Premature baby 96 4.7% 7 33
Maternal exposure during pregnancy 88 4.3% 1 18

Other Indications for DIDANOSINE

Hiv infection (1,259) Product used for unknown indication (407) Antiretroviral therapy (171) Chronic hepatitis c (40) Hepatitis c (37) Acquired immunodeficiency syndrome (24) Maternal exposure timing unspecified (20) Perinatal hiv infection (19) Hiv infection cdc category c (18) Foetal exposure during pregnancy (16)

Other Drugs Used for Hiv infection who clinical stage iii

LAMIVUDINE (52) EFAVIRENZ (35) NEVIRAPINE (32) EMTRICITABINE (28) ZIDOVUDINE (27) TENOFOVIR (25) STAVUDINE (21) ABACAVIR (16) RITONAVIR (10) LOPINAVIR (9)

Related Pages

DIDANOSINE Full Profile All Hiv infection who clinical stage iii Drugs DIDANOSINE Demographics DIDANOSINE Timeline